0102030405
Trametinib (DMSO) Intermediates CAS NO 871700-24-2 Pharmaceutical Intermediates
02
introduce
3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-5-Hydroxy-6,8-Dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione is a novel chemical compound that has garnered attention in the pharmaceutical industry due to its unique properties and potential therapeutic applications. This compound is characterized by its intricate structure, which includes a cyclopropyl group, a fluorinated iodophenyl moiety, and a pyrido-pyrimidine core. Its complex design enhances its biological activity, making it a promising candidate for drug development.
02
Physical and chemical properties
3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-5-Hydroxy-6,8-Dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione possesses several key physical and chemical properties that enhance its utility in pharmaceutical applications:
- Molecular Formula: C18H15FIN3O4
- Molecular Weight: 483.23 g/mol
- Appearance: Typically presented as a white to off-white crystalline powder.
- Solubility: Soluble in organic solvents such as dimethyl sulfoxide (DMSO) and methanol, facilitating its use in various formulations.
- Stability: Exhibits good stability under standard laboratory conditions, making it suitable for long-term storage and use in diverse applications.
The advantages of 3-Cyclopropyl-1-(2-Fluoro-4-Iodophenyl)-5-Hydroxy-6,8-Dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione extend beyond its chemical properties, making it a preferred choice for researchers and pharmaceutical developers:
- Targeted Therapeutic Potential: The unique structure of this compound allows for selective interaction with specific biological targets, enhancing its potential as a therapeutic agent.
- High Bioactivity: This compound has demonstrated significant bioactivity in various preclinical studies, indicating its potential effectiveness in treating complex diseases, including cancer.




